These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9571651)

  • 1. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.
    Meltzer CC; Smith G; DeKosky ST; Pollock BG; Mathis CA; Moore RY; Kupfer DJ; Reynolds CF
    Neuropsychopharmacology; 1998 Jun; 18(6):407-30. PubMed ID: 9571651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonergic system in ageing and Alzheimer's disease.
    Rodríguez JJ; Noristani HN; Verkhratsky A
    Prog Neurobiol; 2012 Oct; 99(1):15-41. PubMed ID: 22766041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropharmacology and receptor studies in the elderly].
    Meltzer CC
    Rev Neurol; 2002 Oct 16-31; 35(8):767-77. PubMed ID: 12402232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
    Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
    Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Olabarria M; Verkhratsky A; Rodríguez JJ
    Eur J Neurosci; 2010 Jul; 32(1):71-9. PubMed ID: 20576032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of the 5-HT(1A) receptor in relation to human cognition.
    Borg J
    Behav Brain Res; 2008 Dec; 195(1):103-11. PubMed ID: 18606193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific expression of the serotonin-receptor 5-HT(2C) in natural killer cells in Alzheimer's dementia.
    Martins LC; Rocha NP; Torres KC; Dos Santos RR; França GS; de Moraes EN; Mukhamedyarov MA; Zefirov AL; Rizvanov AA; Kiyasov AP; Vieira LB; Guimarães MM; Yalvaç ME; Teixeira AL; Bicalho MA; Janka Z; Romano-Silva MA; Palotás A; Reis HJ
    J Neuroimmunol; 2012 Oct; 251(1-2):73-9. PubMed ID: 22766135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diet on serotonergic neurotransmission in depression.
    Shabbir F; Patel A; Mattison C; Bose S; Krishnamohan R; Sweeney E; Sandhu S; Nel W; Rais A; Sandhu R; Ngu N; Sharma S
    Neurochem Int; 2013 Feb; 62(3):324-9. PubMed ID: 23306210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression.
    Hendricksen M; Thomas AJ; Ferrier IN; Ince P; O'Brien JT
    Am J Psychiatry; 2004 Jun; 161(6):1096-102. PubMed ID: 15169699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine neurons in aging and Alzheimer's disease.
    Palmer AM; DeKosky ST
    J Neural Transm Gen Sect; 1993; 91(2-3):135-59. PubMed ID: 8099796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacology and receptor studies in the elderly.
    Meltzer CC
    J Geriatr Psychiatry Neurol; 1999; 12(3):137-49. PubMed ID: 10593702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
    Truchot L; Costes SN; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Croisile B; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
    Neurology; 2007 Sep; 69(10):1012-7. PubMed ID: 17785670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.